Amdocs Limited (NASDAQ:DOX) Receives Average Rating of “Hold” from Analysts

Amdocs Limited (NASDAQ:DOX) has been assigned an average recommendation of “Hold” from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $86.6667.

DOX has been the topic of a number of recent research reports. Stifel Nicolaus cut their price target on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a report on Thursday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Amdocs in a report on Friday, May 8th. Wall Street Zen lowered Amdocs from a “buy” rating to a “hold” rating in a report on Saturday. Barclays reduced their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Finally, Cfra downgraded Amdocs to a “sell” rating in a research note on Thursday.

Amdocs Stock Down 2.2%

Shares of Amdocs stock traded down $1.35 during midday trading on Friday, hitting $60.58. The company’s stock had a trading volume of 1,311,065 shares, compared to its average volume of 1,055,292. The firm has a market capitalization of $6.54 billion, a P/E ratio of 12.12, a PEG ratio of 0.98 and a beta of 0.40. The stock has a 50-day simple moving average of $65.25 and a 200-day simple moving average of $73.56. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23. Amdocs has a 1-year low of $59.40 and a 1-year high of $95.41.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings results on Wednesday, May 13th. The technology company reported $1.78 EPS for the quarter, topping the consensus estimate of $1.77 by $0.01. Amdocs had a net margin of 11.81% and a return on equity of 19.67%. The business had revenue of $1.17 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the company posted $1.78 earnings per share. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. Amdocs has set its FY 2026 guidance at 7.340-7.480 EPS and its Q3 2026 guidance at 1.810-1.870 EPS. As a group, sell-side analysts expect that Amdocs will post 7.41 earnings per share for the current year.

Amdocs Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be issued a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date is Tuesday, June 30th. Amdocs’s dividend payout ratio is 45.40%.

Key Amdocs News

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Amdocs beat quarterly earnings estimates with EPS of $1.78 and matched revenue expectations at $1.17 billion, while revenue still rose 3.9% year over year. Amdocs earnings release and conference call
• Positive Sentiment: Management lifted fiscal 2026 guidance, signaling confidence in continued growth and profitability after the quarter. Zacks on Amdocs Q2 earnings
• Positive Sentiment: The company highlighted progress in GenAI and “agentic telco” initiatives, including launching Telco Agents in Google’s Gemini Enterprise marketplace. Amdocs Telco Agents announcement
• Positive Sentiment: Several new customer wins and platform expansions were announced, including deals with Lumen, Vodafone Ireland, Telefónica Móviles Argentina, and Qué tal Móvil, supporting backlog and long-term demand. Lumen and Amdocs cloud migration announcement
• Neutral Sentiment: Amdocs also announced its third-quarter investor conference schedule, which is routine investor-relations news rather than a direct business catalyst. Amdocs investor conference schedule
• Neutral Sentiment: The board declared a quarterly dividend, which is supportive for income investors but not likely the main driver of trading today.

Institutional Investors Weigh In On Amdocs

Hedge funds have recently modified their holdings of the business. Root Financial Partners LLC acquired a new stake in Amdocs in the 3rd quarter worth $26,000. WealthCollab LLC raised its position in shares of Amdocs by 94.5% during the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after buying an additional 173 shares during the last quarter. Atlantic Union Bankshares Corp bought a new position in Amdocs during the third quarter valued at about $37,000. BOK Financial Private Wealth Inc. bought a new position in Amdocs during the fourth quarter valued at about $37,000. Finally, Los Angeles Capital Management LLC acquired a new position in Amdocs in the 4th quarter valued at approximately $39,000. 92.02% of the stock is owned by institutional investors.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.